News from Cambridge Phenotyping
uncovering the earliest signs of Alzheimer’s disease
The entorhinal cortex and hippocampus, regions in the brain’s medial temporal lobe, are the first to exhibit neurodegeneration in Alzheimer’s. Work pioneered by Nobel Laureate Prof John O’Keefe (UK DRI Associate Member at UCL) has identified that neurons in these...
Cambridge Phenotyping Awarded for Innovative Solutions
Cambridge Phenotyping was recently nominated and won the ‘Investment into Innovative Solutions’ award at the 15th annual European Sails 2023 event!
Best Emerging Tech nomination
Cambridge Phenotyping has been nominated for the Best Emerging Tech Award by the Vilnius TechFusion Startup Awards 2022
Publication pre-print: A novel fully automated system for lifelong continuous phenotyping of mouse cognition and behaviour
Cambridge Phenotyping presents a new fully automated AI-driven home-cage system for cognitive and behavioural phenotyping in mice. The system incorporates spontaneous alternation T-maze, novel-object recognition and object-in-place recognition tests combined with...
Cambridge Phenotyping attracts 610K EUR investment
Coinvest, the acceleration fund 70V and business angels invest in Cambridge Phenotyping, a company founded by neuroscientists Julija Krupic and Marius Bauza.
From UK Dementia Research Institute
Just imagine that you have your mouse, which has received no training. You put it in the cage, close it up and walk away, that is it. The system does all the testing for you, 24/7, with the data put out in near real time so you can run all the analysis that same day.